🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Dublin
Clinical trial register · Ireland

Clinical Trials in Dublin

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 615 matching records held by the registry are in this view. Synced 22 Sep 2026, 03:15 UTC
615
Studies in scope
all four open statuses
323
Recruiting now
open to new participants
181
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 323 recruiting studies
Phase 3 98 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC 36 University College Dublin 21 Royal College of Surgeons, Ireland 18 AbbVie 16 Bristol-Myers Squibb 14
Site location
Dublin 483 Cork 170 Galway 124 Limerick 56 Waterford 51
All 37 locations
Target enrolment
to
483 of 615 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Active, closed
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445 Ulcerative Colitis
Janssen Research & Development, LLC
Phase 2/3
1,064
Dublin, Galway
2019-09-26
Active, closed
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04095364 Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8
NRG Oncology
Phase 3
450
Cork, Dublin
2019-09-20
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048 Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
AbbVie
Phase 3
165
Dublin
2019-09-06
Recruiting
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
NCT03997643 Head and Neck Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2
90
Wilton, Galway, Rathgar, Dublin
2019-09-06
Recruiting
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494 Lymphoblastic Lymphoma, Childhood
University Hospital Muenster
Phase 3
683
Dublin
2019-08-23
Active, closed
A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
NCT04002297 Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
BeOne Medicines
Phase 3
510
Cork, Dublin, Galway, Limerick, Waterford
2019-08-20
Recruiting
Pan Tumor Rollover Study
NCT03899155 Cancer
Bristol-Myers Squibb
Phase 2
1,500
Dublin, Limerick
2019-08-09
Active, closed
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
NCT04008030 Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 3
839
Dublin, Limerick
2019-08-05
Active, closed
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
NCT03924895 Urinary Bladder Cancer, Muscle-invasive
Merck Sharp & Dohme LLC
Phase 3
595
Dublin, Waterford
2019-07-24
Active, closed
A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects
NCT04034498 Perimembranous Ventricular Septal Defect
Occlutech International AB
Observational
50
Dublin
2019-07-07
Active, closed
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
NCT03878446 Short Stature Children Born Small for Gestational Age (SGA)
Novo Nordisk A/S
Phase 2
62
Dublin
2019-07-04
Active, closed
SIRONA 2 Trial Heart Failure NYHA Class III
NCT04012944 Heart Failure NYHA Class III
Endotronix, Inc.
Not applicable
81
Dublin
2019-06-26
Recruiting
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
NCT03818503 Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Dublin, Galway
2019-06-24
Active, closed
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
NCT03969004 Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3
415
Dublin, Cork, Galway
2019-06-04
By invitation
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
NCT03859895 Paget Disease
University of Edinburgh
Observational
287
Dublin
2019-04-05
Active, closed
Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
NCT03869892 Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier
Phase 3
856
Cork, Dublin
2019-03-21
Active, closed
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy
NCT03839771 Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Cork, Dublin, Galway
2019-03-01
Active, closed
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
NCT03754790 Hemophilia
Genzyme, a Sanofi Company
Phase 3
281
Crumlin, Dublin
2019-01-09
Active, closed
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
NCT03725059 Breast Cancer
Merck Sharp & Dohme LLC
Phase 3
1,240
Cork, Dublin
2018-12-27
Active, closed
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
NCT03765918 Head and Neck Neoplasms
Merck Sharp & Dohme LLC
Phase 3
714
Dublin
2018-12-17
Active, closed
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
NCT03742895 Advanced Solid Neoplasms
Merck Sharp & Dohme LLC
Phase 2
329
Dublin, Cork
2018-12-12
Active, closed
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
NCT03701334 Early Breast Cancer
Novartis Pharmaceuticals
Phase 3
5,101
Wilton, County Limerick, Dublin, Waterford
2018-12-07
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507 Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
507
Dublin
2018-11-28
Active, closed
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
NCT03539536 Non-small Cell Lung Cancer
AbbVie
Phase 2
270
Wilton, Dublin, Elm Park
2018-10-10
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
NCT04174157 Spinal Muscular Atrophy (SMA)
Novartis Pharmaceuticals
Observational
700
Dublin
2018-09-25
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
NCT03486873 Solid Tumors, Hematologic Malignancies
Merck Sharp & Dohme LLC
Phase 3
3,500
Dublin
2018-08-21
Active, closed
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03568318 Atopic Dermatitis
AbbVie
Phase 3
1,533
Dublin, Cork, Waterford
2018-08-09
Active, closed
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
NCT03519945 Ulcerative Colitis
Eli Lilly and Company
Phase 3
1,058
Dublin
2018-07-18
Active, closed
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
NCT03755791 Hepatocellular Carcinoma
Exelixis
Phase 3
837
Dublin
2018-06-10
By invitation
Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study
NCT04260269 Solid Tumor
Helsinki University Central Hospital
Observational
200
Dublin
2018-06-01
Active, closed
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
NCT03523858 Progressive Multiple Sclerosis (PMS)
Hoffmann-La Roche
Phase 3
927
Cork, Dublin
2018-05-28
Active, closed
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
NCT03425643 Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
797
Wilton, Dublin, Limerick
2018-04-24
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738 Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Dublin
2018-04-23
Active, closed
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
NCT03330847 Metastatic Triple Negative Breast Cancer
AstraZeneca
Phase 2
273
Cork, Dublin
2018-03-07
Active, closed
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
NCT03367702 Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology
Phase 3
692
Dublin
2018-02-01
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476 X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Dublin
2017-09-12
Active, closed
Paediatric Hepatic International Tumour Trial
NCT03017326 Hepatoblastoma, Carcinoma, Hepatocellular
University of Birmingham
Phase 3
450
Dublin
2017-08-24
Active, closed
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
NCT02889874 Early Stage Breast Carcinoma
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Dublin, Galway
2017-08-21
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT03151629 Prostate Cancer
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Dublin, Sligo
2017-07-21
Active, closed
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
NCT03006068 Ulcerative Colitis (UC)
AbbVie
Phase 3
950
Dublin, Elm Park, Cork, Galway
2017-01-31
Active, closed
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
NCT02811861 Renal Cell Carcinoma
Eisai Inc.
Phase 3
1,069
Cork, Dublin, Galway
2016-10-13
Active, closed
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
NCT02655016 Ovarian Neoplasms
Tesaro, Inc.
Phase 3
733
Dublin, Dunmore RoadWaterford, Galway
2016-07-11
Active, closed
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
NCT03469674 Endometrial Cancer Stage I, Endometrial Cancer Stage II
Leiden University Medical Center
Phase 3
550
Dublin
2016-06-10
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707 Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht
Phase 3
20,000
Cork, Dublin, Galway, Waterford
2016-04-11
Active, closed
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
NCT02724163 Acute Myeloid Leukaemia
University of Birmingham
Phase 3
700
Dublin
2016-04
Active, closed
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
NCT02629159 Rheumatoid Arthritis
AbbVie
Phase 3
1,629
Dublin
2015-12-01
Active, closed
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153 Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma
National Cancer Institute (NCI)
Phase 3
1,301
Dublin, Galway, Waterford
2015-11-10
Recruiting
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
NCT05663008 ALS (Amyotrophic Lateral Sclerosis), Postpoliomyelitis Syndrome, Spinal Muscular Atrophy
University of Dublin, Trinity College
Observational
400
Dublin
2015-10-01
Active, closed
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
NCT02804815 Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer
University College, London
Phase 3
11,000
Cork, Dublin, Galway, Limerick, Sligo, Waterford
2015-10
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842 Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Cork, Dublin
2015-10
Active, closed
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT02375204 Germ Cell Tumor, Teratoma, Choriocarcinoma, Germinoma
Alliance for Clinical Trials in Oncology
Phase 3
420
Dublin
2015-08-06
Active, closed
PALbociclib CoLlaborative Adjuvant Study
NCT02513394 Breast Cancer
Alliance Foundation Trials, LLC.
Phase 3
5,796
Cork, Dublin, Limerick, Sligo, Waterford
2015-08
Active, closed
CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)
NCT04116047 Oropharyngeal Cancer
University of Birmingham
Phase 3
785
Dublin
2015-07
Recruiting
An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
NCT02265770 Childhood Ependymoma
Centre Leon Berard
Phase 2/3
536
Dublin
2015-06-02
Active, closed
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
NCT02362503 HIV Infections
ViiV Healthcare
Phase 3
371
Dublin
2015-02-23
Active, closed
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
NCT02308085 Early Breast Cancer
ETOP IBCSG Partners Foundation
Not applicable
518
Dublin, Galway, Limerick, Waterford
2014-12-04
Active, closed
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
NCT02066220 Brain Tumors
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Dublin
2014-06
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119 Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Dublin
2014-06
Active, closed
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
NCT02446405 Prostatic Neoplasms
University of Sydney
Phase 3
1,125
Beaumont, Dublin, Galway, Tallaght, Waterford
2014-03
Active, closed
Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
NCT02446444 Prostatic Neoplasms
University of Sydney
Phase 3
802
Cork, Galway, Dublin
2014-03
Recruiting
Biomechanical Analysis of Dynamic Tasks and Muscular Strength Following Anterior Cruciate Ligament Reconstruction
NCT02771548 Rupture of Anterior Cruciate Ligament
Dr Neil Welch ASCC
Observational
1,000
Dublin
2014-01
Active, closed
TAILORx Tissue Bank
NCT02050750 Breast Cancer
Cancer Trials Ireland
Observational
600
Cork, Donegal, Dublin, Galway, Limerick, Sligo, Waterford
2013-12
Active, closed
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
NCT01957436 Metastatic Prostate Cancer
UNICANCER
Phase 3
1,173
Cork, Dublin, Galway
2013-11-13
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686 Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
700
Dublin
2013-09-09
Active, closed
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
NCT01872975 Stage IB Breast Cancer, Stage II Breast Cancer
NSABP Foundation Inc
Not applicable
1,636
Dublin, Galway
2013-08
Recruiting
European Registry on the Management of Helicobacter Pylori Infection
NCT02328131 H. Pylori Infection
Javier P. Gisbert
Observational
10,000
Dublin
2013-06
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489 Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Dublin
2013-05-30
Active, closed
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
NCT01848561 Ulcerative Colitis (UC)
AbbVie
Observational
8,250
Abbotstown, Dublin, Elm Park, Galway
2013-04-29
Recruiting
Breast Cancer Proteomics and Molecular Heterogeneity
NCT01840293 Primary Breast Cancer, Recurrent/Metastatic Breast Cancer
Cancer Trials Ireland
Observational
1,780
Cork, Dublin, Limerick, Waterford
2013-02
Active, closed
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
NCT01760005 Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Washington University School of Medicine
Phase 2/3
490
Dublin
2012-12
Active, closed
Prostate Advances in Comparative Evidence
NCT01584258 Prostate Cancer
Royal Marsden NHS Foundation Trust
Phase 3
2,205
Dublin
2012-08-07
By invitation
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
NCT02040714 Legg Calve Perthes Disease
Texas Scottish Rite Hospital for Children
Observational
1,500
Dublin
2012-08
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
NCT01574053 Huntington's Disease
CHDI Foundation, Inc.
Observational
35,000
Dublin
2012-07
Recruiting
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
NCT01299168 Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
University of Alberta
Observational
500
Dublin
2011-05
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037 Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI)
Phase 3
5,018
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2011-02-28
Active, closed
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NCT01169337 Light Chain Deposition Disease, Smoldering Multiple Myeloma
National Cancer Institute (NCI)
Phase 3
226
Dublin, Galway
2011-01-24
Active, closed
Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT01101425 Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
Cork, Dublin, Waterford
2010-12
Active, closed
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
NCT00951535 Prostate Cancer
Cancer Trials Ireland
Phase 2
251
Cork, Dublin
2009-07-20
Recruiting
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
NCT00825929 HIV Infections
Radboud University Medical Center
Observational
176
Dublin
2009-02
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180 Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
National Cancer Institute (NCI)
Phase 3
10,273
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2006-04-07
Recruiting
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
NCT01704716 Neuroblastoma
St. Anna Kinderkrebsforschung
Phase 3
3,300
Dublin
2002-02
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
NCT02832245 Venous Thromboembolism
Manuel Monreal
Observational
120,000
Dublin
2001-03
By invitation
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
NCT02699736 HIV, Hepatitis B, Hepatitis C, AIDS
Rigshospitalet, Denmark
Observational
23,000
Dublin
1994-01
Rows per page Showing 401–483 of 483
Previous 3 4 5
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/dublin?page=5

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.